| Style | Citing Format |
|---|---|
| MLA | Dashtikhavidaki S, Khalili H. "Considerations for Statin Therapy in Patients With Covid-19." Pharmacotherapy, vol. 40, no. 5, 2020, pp. 484-486. |
| APA | Dashtikhavidaki S, Khalili H (2020). Considerations for Statin Therapy in Patients With Covid-19. Pharmacotherapy, 40(5), 484-486. |
| Chicago | Dashtikhavidaki S, Khalili H. "Considerations for Statin Therapy in Patients With Covid-19." Pharmacotherapy 40, no. 5 (2020): 484-486. |
| Harvard | Dashtikhavidaki S, Khalili H (2020) 'Considerations for Statin Therapy in Patients With Covid-19', Pharmacotherapy, 40(5), pp. 484-486. |
| Vancouver | Dashtikhavidaki S, Khalili H. Considerations for Statin Therapy in Patients With Covid-19. Pharmacotherapy. 2020;40(5):484-486. |
| BibTex | @article{ author = {Dashtikhavidaki S and Khalili H}, title = {Considerations for Statin Therapy in Patients With Covid-19}, journal = {Pharmacotherapy}, volume = {40}, number = {5}, pages = {484-486}, year = {2020} } |
| RIS | TY - JOUR AU - Dashtikhavidaki S AU - Khalili H TI - Considerations for Statin Therapy in Patients With Covid-19 JO - Pharmacotherapy VL - 40 IS - 5 SP - 484 EP - 486 PY - 2020 ER - |